{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:30:26Z","timestamp":1791559826397,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\u03b2II-Spectrin (\u03b22SP), a Smad3\/4 adaptor protein during transforming growth factor (TGF) \u03b2\/Smad signal pathway, plays a critical role in suppressing hepatocarcinogenesis. Dedifferentiation is a distinctive feature of cancer progression. Therefore, we investigated whether the disruption of \u03b22SP contributed to tumorigenesis of hepatocellular carcinoma (HCC) through the dedifferentiation. Down-regulation of \u03b22SP in hepatocytes was observed in cirrhotic liver and HCC. The level of \u03b22SP expression was closely associated with the differentiation status of hepatocytes in rat model of hepatocarcinogenesis and clinical specimens. Transgenic expression of \u03b22SP in HCC cells promoted the differentiation of HCC cells and suppressed the growth of HCC cells in vitro. Efficient transduction of \u03b22SP into liver CSCs resulted in a reduction in colony formation ability, spheroid formation capacity, invasive activity, chemo-resistance properties, tumorigenicity in vivo. In addition, \u03b22 spectrin exerted its effect through \u03b2 catenin in liver CSCs. In conclusion, \u03b22 spectrin repressed the properties of liver CSCs through inducing differentiation; thus, strategies to restore its levels and activities would be a novel strategy for HCC prevention and differentiation therapy<\/jats:p>","DOI":"10.1038\/s41419-018-0456-6","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:28:42Z","timestamp":1522808922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u03b22 spectrin-mediated differentiation repressed the properties of liver cancer stem cells through \u03b2-catenin"],"prefix":"10.1038","volume":"9","author":[{"given":"Yuhua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1952-654X","authenticated-orcid":false,"given":"Yuhu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"key":"456_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin.\n                           61, 69\u201390 (2011).","journal-title":"CA Cancer J. Clin."},{"key":"456_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/hep.20155","volume":"39","author":"NL Lazarevich","year":"2004","unstructured":"Lazarevich, N. L. et al. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology\n                           39, 1038\u20131047 (2004).","journal-title":"Hepatology"},{"key":"456_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng0802-339","volume":"31","author":"SS Thorgeirsson","year":"2002","unstructured":"Thorgeirsson, S. S. & Grisham, J. W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet.\n                           31, 339\u2013346 (2002).","journal-title":"Nat. Genet."},{"key":"456_CR4","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/hep.24530","volume":"54","author":"W Sun","year":"2011","unstructured":"Sun, W. et al. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology\n                           54, 1259\u20131272 (2011).","journal-title":"Hepatology"},{"key":"456_CR5","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/hep.22510","volume":"48","author":"C Yin","year":"2008","unstructured":"Yin, C. et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology\n                           48, 1528\u20131539 (2008).","journal-title":"Hepatology"},{"key":"456_CR6","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/hep.24647","volume":"54","author":"X Zeng","year":"2011","unstructured":"Zeng, X. et al. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology\n                           54, 2036\u20132047 (2011).","journal-title":"Hepatology"},{"key":"456_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/hep.28367","volume":"63","author":"KH Jung","year":"2016","unstructured":"Jung, K. H. et al. Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis. Hepatology\n                           63, 864\u2013879 (2016).","journal-title":"Hepatology"},{"key":"456_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1101\/sqb.2008.73.041","volume":"73","author":"GQ Daley","year":"2008","unstructured":"Daley, G. Q. Common themes of dedifferentiation in somatic cell reprogramming and cancer. Cold Spring Harb. Symp. Quant. Biol.\n                           73, 171\u2013174 (2008).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"456_CR9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.4161\/cbt.8.18.9843","volume":"8","author":"Z Yao","year":"2009","unstructured":"Yao, Z. & Mishra, L. Cancer stem cells and hepatocellular carcinoma. Cancer Biol. Ther.\n                           8, 1691\u20131698 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"456_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/hep.28485","volume":"64","author":"T Oikawa","year":"2016","unstructured":"Oikawa, T. Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers. Hepatology\n                           64, 645\u2013651 (2016).","journal-title":"Hepatology"},{"key":"456_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.22704","volume":"49","author":"L Mishra","year":"2009","unstructured":"Mishra, L. et al. Liver stem cells and hepatocellular carcinoma. Hepatology\n                           49, 318\u2013329 (2009).","journal-title":"Hepatology"},{"key":"456_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1118389","volume":"310","author":"L Mishra","year":"2005","unstructured":"Mishra, L., Derynck, R. & Mishra, B. Transforming growth factor-beta signaling in stem cells and cancer. Science\n                           310, 68\u201371 (2005).","journal-title":"Science"},{"key":"456_CR13","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1158\/0008-5472.CAN-04-4585","volume":"65","author":"Y Tang","year":"2005","unstructured":"Tang, Y. et al. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res.\n                           65, 4228\u20134237 (2005).","journal-title":"Cancer Res."},{"key":"456_CR14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/hep.22460","volume":"48","author":"HJ Baek","year":"2008","unstructured":"Baek, H. J. et al. Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis. Hepatology\n                           48, 1128\u20131137 (2008).","journal-title":"Hepatology"},{"key":"456_CR15","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1073\/pnas.0705395105","volume":"105","author":"Y Tang","year":"2008","unstructured":"Tang, Y. et al. Progenitor\/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc. Natl Acad. Sci. USA\n                           105, 2445\u20132450 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"456_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/onc.2008.448","volume":"28","author":"L Lin","year":"2009","unstructured":"Lin, L. et al. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene\n                           28, 961\u2013972 (2009).","journal-title":"Oncogene"},{"key":"456_CR17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/hep.27558","volume":"61","author":"X Zhi","year":"2015","unstructured":"Zhi, X. et al. betaII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology\n                           61, 598\u2013612 (2015).","journal-title":"Hepatology"},{"key":"456_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/hep.28951","volume":"65","author":"A Mitra","year":"2017","unstructured":"Mitra A., et al. IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient beta2-spectrin+\/\u2212 mice. Hepatology\n                           65, 1222-1236 (2017).","journal-title":"Hepatology"},{"key":"456_CR19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/hep.28927","volume":"65","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. Loss of the transforming growth factor-beta effector beta2-Spectrin promotes genomic instability. Hepatology\n                           65, 678\u2013693 (2017).","journal-title":"Hepatology"},{"key":"456_CR20","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/hep.24111","volume":"53","author":"A Thenappan","year":"2011","unstructured":"Thenappan, A. et al. Loss of transforming growth factor beta adaptor protein beta-2 spectrin leads to delayed liver regeneration in mice. Hepatol. (Baltim., Md)\n                           53, 1641\u20131650 (2011).","journal-title":"Hepatol. (Baltim., Md)"},{"key":"456_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s13277-015-3857-5","volume":"37","author":"XX He","year":"2016","unstructured":"He, X. X. et al. CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo. Tumour Biol.\n                           37, 807\u2013815 (2016).","journal-title":"Tumour Biol."},{"key":"456_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep08705","volume":"5","author":"X He","year":"2015","unstructured":"He, X. et al. Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo. Sci. Rep.\n                           5, 8705 (2015).","journal-title":"Sci. Rep."},{"key":"456_CR23","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.18632\/oncotarget.2988","volume":"6","author":"X He","year":"2015","unstructured":"He, X. et al. Functional repair of p53 mutation in colorectal cancer cells using trans-splicing. Oncotarget\n                           6, 2034\u20132045 (2015).","journal-title":"Oncotarget"},{"key":"456_CR24","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s13277-014-2389-8","volume":"36","author":"X He","year":"2015","unstructured":"He, X. et al. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo. Tumour Biol.\n                           36, 1437\u20131444 (2015).","journal-title":"Tumour Biol."},{"key":"456_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1582-4934.2011.01290.x","volume":"16","author":"Z Wang","year":"2012","unstructured":"Wang, Z. et al. Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis. J. Cell Mol. Med.\n                           16, 118\u2013128 (2012).","journal-title":"J. Cell Mol. Med."},{"key":"456_CR26","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1053\/j.gastro.2007.04.025","volume":"132","author":"S Ma","year":"2007","unstructured":"Ma, S. et al. Identification and characterization of tumorigenic liver cancer stem\/progenitor cells. Gastroenterology\n                           132, 2542\u20132556 (2007).","journal-title":"Gastroenterology"},{"key":"456_CR27","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/sj.onc.1210811","volume":"27","author":"S Ma","year":"2008","unstructured":"Ma, S. et al. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt\/PKB survival pathway. Oncogene\n                           27, 1749\u20131758 (2008).","journal-title":"Oncogene"},{"key":"456_CR28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jhep.2013.07.001","volume":"59","author":"F Pez","year":"2013","unstructured":"Pez, F. et al. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J. Hepatol.\n                           59, 1107\u20131117 (2013).","journal-title":"J. Hepatol."},{"key":"456_CR29","doi-asserted-by":"publisher","first-page":"10831","DOI":"10.1158\/0008-5472.CAN-07-0908","volume":"67","author":"T Yamashita","year":"2007","unstructured":"Yamashita, T., Budhu, A., Forgues, M. & Wang, X. W. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res.\n                           67, 10831\u201310839 (2007).","journal-title":"Cancer Res."},{"key":"456_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo, S. et al. Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell\n                           14, 471\u2013484 (2008).","journal-title":"Cancer Cell"},{"key":"456_CR31","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1158\/0008-5472.CAN-07-6691","volume":"68","author":"W Yang","year":"2008","unstructured":"Yang, W. et al. Wnt\/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res.\n                           68, 4287\u20134295 (2008).","journal-title":"Cancer Res."},{"key":"456_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2353\/ajpath.2010.090300","volume":"176","author":"G Zulehner","year":"2010","unstructured":"Zulehner, G. et al. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. Am. J. Pathol.\n                           176, 472\u2013481 (2010).","journal-title":"Am. J. Pathol."},{"key":"456_CR33","doi-asserted-by":"publisher","first-page":"18384","DOI":"10.1073\/pnas.1116386108","volume":"108","author":"EY Wang","year":"2011","unstructured":"Wang, E. Y. et al. Depletion of beta-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development. Proc. Natl Acad. Sci. USA\n                           108, 18384\u201318389 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"456_CR34","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1158\/0008-5472.CAN-13-3275","volume":"74","author":"S Mokkapati","year":"2014","unstructured":"Mokkapati, S. et al. beta-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res.\n                           74, 4515\u20134525 (2014).","journal-title":"Cancer Res."},{"key":"456_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.canlet.2016.03.033","volume":"379","author":"LH Katz","year":"2016","unstructured":"Katz, L. H. et al. TGF-beta signaling in liver and gastrointestinal cancers. Cancer Lett.\n                           379, 166\u2013172 (2016).","journal-title":"Cancer Lett."},{"key":"456_CR36","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/j.1478-3231.2012.02812.x","volume":"32","author":"Z Wang","year":"2012","unstructured":"Wang, Z. et al. beta-2 spectrin is involved in hepatocyte proliferation through the interaction of TGFbeta\/Smad and PI3K\/AKT signalling. Liver Int.\n                           32, 1103\u20131111 (2012).","journal-title":"Liver Int."},{"key":"456_CR37","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1038\/sj.onc.1210513","volume":"26","author":"K Kitisin","year":"2007","unstructured":"Kitisin, K. et al. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene\n                           26, 7103\u20137110 (2007).","journal-title":"Oncogene"},{"key":"456_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.canlet.2012.05.001","volume":"338","author":"TK Lee","year":"2013","unstructured":"Lee, T. K., Cheung, V. C. & Ng, I. O. Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma. Cancer Lett.\n                           338, 101\u2013109 (2013).","journal-title":"Cancer Lett."},{"key":"456_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbrc.2017.07.041","volume":"491","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models. Biochem. Biophys. Res. Commun.\n                           491, 469\u2013477 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"456_CR40","doi-asserted-by":"crossref","first-page":"29346","DOI":"10.18632\/oncotarget.8830","volume":"7","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells. Oncotarget\n                           7, 29346\u201329358 (2016).","journal-title":"Oncotarget"},{"key":"456_CR41","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/hep.24128","volume":"53","author":"HJ Baek","year":"2011","unstructured":"Baek, H. J. et al. Transforming growth factor-beta adaptor, beta2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer. Hepatology\n                           53, 1676\u20131684 (2011).","journal-title":"Hepatology"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0456-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:52:08Z","timestamp":1671537128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0456-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,19]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0456-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,19]]},"assertion":[{"value":"24 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"424"}}